RxDoctor Payments Data

Jeffrey Herring, MD

Foot and Ankle Surgery · Nashville, TNNPI 1285634824

Payments from drug & device makers

What this record shows

This record is dominated by education: $4,416 of the $5,322 with a category attached, or 83.0%. 10 manufacturers reported payments, led by Arthrex at 49.6% of the total. Reporting peaked in 2022 at $2,938 and has fallen 98.4% since, to $46 in 2024.

$5,322in general payments, 2019–2025

Across 41 payments — averaging $129.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$3K
  • Alpha Orthopedic Systems$2K
  • Amgen$167
  • Smith+Nephew$66
  • DJO, LLC$31
  • Zimmer Biomet$30
  • plus $74 from 4 others
$16,547in research payments, 2019–2025

Across 10 payments — averaging $1654.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$17K

What the payments were for

  • Food & beverage$90617%
  • Education$4,41683%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex16$2,637
Alpha Orthopedic Systems4$2,317
Amgen(2 entities)13$167
Smith+Nephew2$66
DJO, LLC1$31
Zimmer Biomet1$30
Stryker1$29
Johnson & Johnson1$16
Music City Medical Technologies, LLC1$14
Orthofix Medical, Inc.1$14

How this compares

$5,322 in reported general payments places this provider in the 55th percentile of 145 foot and ankle surgery providers in Tennessee.

See all foot and ankle surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$36,199
Medicare patients
162
Services billed
482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$218
Cephalexin29$181
Meloxicam40$95

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →